Genomics Personalized Health Market 2028 By Technology, Test Type, End User and Geography | The Insight Partners

Genomics Personalized Health Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (NGS platforms, RT-PCR, Microarray, Genetic Analyzers); Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Others); End User (Academics and Research Institutes, Diagnostic Centers, Others) and Geography

Report Code: TIPRE00007153 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genomics Personalized Health Market - By Technology
1.3.2 Genomics Personalized Health Market - By Test Type
1.3.3 Genomics Personalized Health Market - By End User
1.3.4 Genomics Personalized Health Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GENOMICS PERSONALIZED HEALTH MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. GENOMICS PERSONALIZED HEALTH MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GENOMICS PERSONALIZED HEALTH MARKET - GLOBAL MARKET ANALYSIS
6.1. GENOMICS PERSONALIZED HEALTH - GLOBAL MARKET OVERVIEW
6.2. GENOMICS PERSONALIZED HEALTH - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. NGS PLATFORMS
7.3.1. Overview
7.3.2. NGS platforms Market Forecast and Analysis
7.4. RT-PCR
7.4.1. Overview
7.4.2. RT-PCR Market Forecast and Analysis
7.5. MICROARRAY
7.5.1. Overview
7.5.2. Microarray Market Forecast and Analysis
7.6. GENETIC ANALYZERS
7.6.1. Overview
7.6.2. Genetic Analyzers Market Forecast and Analysis
8. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY TESTING
8.3.1. Overview
8.3.2. Oncology Testing Market Forecast and Analysis
8.4. INFECTIOUS DISEASE TESTING
8.4.1. Overview
8.4.2. Infectious Disease Testing Market Forecast and Analysis
8.5. ORPHAN DISEASE TESTING
8.5.1. Overview
8.5.2. Orphan Disease Testing Market Forecast and Analysis
8.6. AUTOIMMUNE DISEASE TESTING
8.6.1. Overview
8.6.2. Autoimmune Disease Testing Market Forecast and Analysis
8.7. OBSTETRICS TESTING
8.7.1. Overview
8.7.2. Obstetrics Testing Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. ACADEMICS AND RESEARCH INSTITUTES
9.3.1. Overview
9.3.2. Academics and Research Institutes Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. GENOMICS PERSONALIZED HEALTH MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Genomics Personalized Health Market Overview
10.1.2 North America Genomics Personalized Health Market Forecasts and Analysis
10.1.3 North America Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.1.4 North America Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.1.5 North America Genomics Personalized Health Market Forecasts and Analysis - By End User
10.1.6 North America Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.1.6.1 United States Genomics Personalized Health Market
10.1.6.1.1 United States Genomics Personalized Health Market by Technology
10.1.6.1.2 United States Genomics Personalized Health Market by Test Type
10.1.6.1.3 United States Genomics Personalized Health Market by End User
10.1.6.2 Canada Genomics Personalized Health Market
10.1.6.2.1 Canada Genomics Personalized Health Market by Technology
10.1.6.2.2 Canada Genomics Personalized Health Market by Test Type
10.1.6.2.3 Canada Genomics Personalized Health Market by End User
10.1.6.3 Mexico Genomics Personalized Health Market
10.1.6.3.1 Mexico Genomics Personalized Health Market by Technology
10.1.6.3.2 Mexico Genomics Personalized Health Market by Test Type
10.1.6.3.3 Mexico Genomics Personalized Health Market by End User
10.2. EUROPE
10.2.1 Europe Genomics Personalized Health Market Overview
10.2.2 Europe Genomics Personalized Health Market Forecasts and Analysis
10.2.3 Europe Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.2.4 Europe Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.2.5 Europe Genomics Personalized Health Market Forecasts and Analysis - By End User
10.2.6 Europe Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Genomics Personalized Health Market
10.2.6.1.1 Germany Genomics Personalized Health Market by Technology
10.2.6.1.2 Germany Genomics Personalized Health Market by Test Type
10.2.6.1.3 Germany Genomics Personalized Health Market by End User
10.2.6.2 France Genomics Personalized Health Market
10.2.6.2.1 France Genomics Personalized Health Market by Technology
10.2.6.2.2 France Genomics Personalized Health Market by Test Type
10.2.6.2.3 France Genomics Personalized Health Market by End User
10.2.6.3 Italy Genomics Personalized Health Market
10.2.6.3.1 Italy Genomics Personalized Health Market by Technology
10.2.6.3.2 Italy Genomics Personalized Health Market by Test Type
10.2.6.3.3 Italy Genomics Personalized Health Market by End User
10.2.6.4 Spain Genomics Personalized Health Market
10.2.6.4.1 Spain Genomics Personalized Health Market by Technology
10.2.6.4.2 Spain Genomics Personalized Health Market by Test Type
10.2.6.4.3 Spain Genomics Personalized Health Market by End User
10.2.6.5 United Kingdom Genomics Personalized Health Market
10.2.6.5.1 United Kingdom Genomics Personalized Health Market by Technology
10.2.6.5.2 United Kingdom Genomics Personalized Health Market by Test Type
10.2.6.5.3 United Kingdom Genomics Personalized Health Market by End User
10.2.6.6 Rest of Europe Genomics Personalized Health Market
10.2.6.6.1 Rest of Europe Genomics Personalized Health Market by Technology
10.2.6.6.2 Rest of Europe Genomics Personalized Health Market by Test Type
10.2.6.6.3 Rest of Europe Genomics Personalized Health Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Genomics Personalized Health Market Overview
10.3.2 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis
10.3.3 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.3.5 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Genomics Personalized Health Market
10.3.6.1.1 Australia Genomics Personalized Health Market by Technology
10.3.6.1.2 Australia Genomics Personalized Health Market by Test Type
10.3.6.1.3 Australia Genomics Personalized Health Market by End User
10.3.6.2 China Genomics Personalized Health Market
10.3.6.2.1 China Genomics Personalized Health Market by Technology
10.3.6.2.2 China Genomics Personalized Health Market by Test Type
10.3.6.2.3 China Genomics Personalized Health Market by End User
10.3.6.3 India Genomics Personalized Health Market
10.3.6.3.1 India Genomics Personalized Health Market by Technology
10.3.6.3.2 India Genomics Personalized Health Market by Test Type
10.3.6.3.3 India Genomics Personalized Health Market by End User
10.3.6.4 Japan Genomics Personalized Health Market
10.3.6.4.1 Japan Genomics Personalized Health Market by Technology
10.3.6.4.2 Japan Genomics Personalized Health Market by Test Type
10.3.6.4.3 Japan Genomics Personalized Health Market by End User
10.3.6.5 South Korea Genomics Personalized Health Market
10.3.6.5.1 South Korea Genomics Personalized Health Market by Technology
10.3.6.5.2 South Korea Genomics Personalized Health Market by Test Type
10.3.6.5.3 South Korea Genomics Personalized Health Market by End User
10.3.6.6 Rest of Asia-Pacific Genomics Personalized Health Market
10.3.6.6.1 Rest of Asia-Pacific Genomics Personalized Health Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Genomics Personalized Health Market by Test Type
10.3.6.6.3 Rest of Asia-Pacific Genomics Personalized Health Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Genomics Personalized Health Market Overview
10.4.2 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis
10.4.3 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.4.5 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Genomics Personalized Health Market
10.4.6.1.1 South Africa Genomics Personalized Health Market by Technology
10.4.6.1.2 South Africa Genomics Personalized Health Market by Test Type
10.4.6.1.3 South Africa Genomics Personalized Health Market by End User
10.4.6.2 Saudi Arabia Genomics Personalized Health Market
10.4.6.2.1 Saudi Arabia Genomics Personalized Health Market by Technology
10.4.6.2.2 Saudi Arabia Genomics Personalized Health Market by Test Type
10.4.6.2.3 Saudi Arabia Genomics Personalized Health Market by End User
10.4.6.3 U.A.E Genomics Personalized Health Market
10.4.6.3.1 U.A.E Genomics Personalized Health Market by Technology
10.4.6.3.2 U.A.E Genomics Personalized Health Market by Test Type
10.4.6.3.3 U.A.E Genomics Personalized Health Market by End User
10.4.6.4 Rest of Middle East and Africa Genomics Personalized Health Market
10.4.6.4.1 Rest of Middle East and Africa Genomics Personalized Health Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Genomics Personalized Health Market by Test Type
10.4.6.4.3 Rest of Middle East and Africa Genomics Personalized Health Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Genomics Personalized Health Market Overview
10.5.2 South and Central America Genomics Personalized Health Market Forecasts and Analysis
10.5.3 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.5.5 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By End User
10.5.6 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Genomics Personalized Health Market
10.5.6.1.1 Brazil Genomics Personalized Health Market by Technology
10.5.6.1.2 Brazil Genomics Personalized Health Market by Test Type
10.5.6.1.3 Brazil Genomics Personalized Health Market by End User
10.5.6.2 Argentina Genomics Personalized Health Market
10.5.6.2.1 Argentina Genomics Personalized Health Market by Technology
10.5.6.2.2 Argentina Genomics Personalized Health Market by Test Type
10.5.6.2.3 Argentina Genomics Personalized Health Market by End User
10.5.6.3 Rest of South and Central America Genomics Personalized Health Market
10.5.6.3.1 Rest of South and Central America Genomics Personalized Health Market by Technology
10.5.6.3.2 Rest of South and Central America Genomics Personalized Health Market by Test Type
10.5.6.3.3 Rest of South and Central America Genomics Personalized Health Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. GENOMICS PERSONALIZED HEALTH MARKET, KEY COMPANY PROFILES
12.1. QIAGEN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ILLUMINA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIO-RAD LABORATORIES, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. INVITAE CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GENETIC TECHNOLOGIES LIMITED
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LONZA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. INTERLEUKIN GENETICS, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DNAGENOTEK
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. QIAGEN
2. Illumina, Inc.
3. Thermo Fisher Scientific, Inc.
4. Bio-Rad Laboratories, Inc.
5. F. Hoffmann-La Roche Ltd
6. Invitae Corporation
7. Genetic Technologies Limited
8. Lonza
9. Interleukin Genetics, Inc
10. DNAGenotek
TIPRE00007153
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount